EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Colonic Submucosa Targeted Delivery of Probiotic and Rhein for Ulcerative Colitis Treatment

Lingqiang Li iD, Linxin Dai, Meisi Lin, Shuang He, Hongye Du, Dasheng Lin, Yanbin Wang, Fenglian Zhang, Sian Tao, Xiaoluo Sun, Xinggui Huang, Haihui Liu und 10 weitere

Advanced Science · 2025-08 · 12 (30)

DOI: 10.1002/advs.202409711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 09.05.2025. Verfasst von Lingqiang Li und 21 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy / School of Modern Chinese Medicine Industry, Chengdu University …. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Probiotics, Drug Delivery Systems, Intestinal Mucosa. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The National Multidisciplinary Innovation Team Project of Traditional Chinese Medicine: Multi-dimensional Evaluation and Multidisciplinary Innovation Team of S…, Provincial Administration of Traditional Chinese Medicine Resource.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic disease. A significant challenge for the management of UC is to achieve delivery of drugs to the multi‐layer colonic barriers, as existing drugs are difficult to penetrate these depths. In this study, a novel drug delivery system using yeast cell wall microparticles (YPs) are developed to co‐encapsulate Bacillus subtilis (BS) and Rhein (Rh) termed Rh‐YBS. This system specifically targets colonic microfold cells, enabling direct delivery of BS to the colonic submucosa. Additionally, Rh enhances BS colonization in the submucosa through floral regulation. Studies indicate that Rh‐YBS can effectively reach and proliferate within the submucosa in vivo. In a DSS‐induced UC mouse model, Rh‐YBS stimulates the CGRP‐related neural pathway; BS activation in the submucosa leads to increased CGRP secretion, prompting goblet cells to secrete mucus and thereby repairing the mucosa. Furthermore, the Rh‐YBS also provide a preventive benefit against UC. In summary, Rh‐YBS represents an innovative drug delivery system for mucosal repair in UC treatment, activating a unique mechanism involving the CGRP‐related neural pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeProbioticsDrug Delivery SystemsIntestinal MucosaAnthraquinonesAnimalsMiceDisease Models, AnimalColonBacillus subtilisMice, Inbred C57BL

Stichwörter der Autor:innen

bacillus subtilisrheinsubmucosal drug delivery systemulcerative colitisyeast cell wall microparticles

Substanzen

Anthraquinonesrhein

Autor:innen und Institutionen

  • State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy / School of Modern Chinese Medicine Industry, Chengdu University of Traditional Chinese Medicine, Chengdu, 611130, China.
  • Chengdu Huashen Technology Group Co., Ltd., Chengdu, 611137, China.
  • College of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, 611130, China.
  • College of Pharmacy, Shenzhen Technology University, Shenzhen, Guangdong, 518118, China.
  • Division of Hematology of Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
  • TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, China.

ORCID-Profile: Lingqiang Li, Jibin Liu, Fei Gao

Förderung

  • National Natural Science Foundation of China
  • The National Multidisciplinary Innovation Team Project of Traditional Chinese Medicine: Multi-dimensional Evaluation and Multidisciplinary Innovation Team of S…
  • Provincial Administration of Traditional Chinese Medicine Resource

Zitieren

APA

Li, L., Dai, L., Lin, M., He, S., Du, H., Lin, D., Wang, Y., Zhang, F., Tao, S., Sun, X., Huang, X., Liu, H., Wang, Q., He, L., Wu, K., You, J., Zhang, M., Fu, C., Tu, H., …, & Gao, F. (2025). Colonic Submucosa Targeted Delivery of Probiotic and Rhein for Ulcerative Colitis Treatment. Advanced Science, 12(30). https://doi.org/10.1002/advs.202409711

Vancouver

Li L, Dai L, Lin M, He S, Du H, Lin D, et al. Colonic Submucosa Targeted Delivery of Probiotic and Rhein for Ulcerative Colitis Treatment. Advanced Science. 2025;12(30). doi:10.1002/advs.202409711

BibTeX
@article{Li2025,
  author = {Li, Lingqiang and Dai, Linxin and Lin, Meisi and He, Shuang and Du, Hongye and Lin, Dasheng and Wang, Yanbin and Zhang, Fenglian and Tao, Sian and Sun, Xiaoluo and Huang, Xinggui and Liu, Haihui and Wang, Qian and He, Lingling and Wu, Kunhe and You, Jieshu and Zhang, Minyue and Fu, Chaomei and Tu, He and Ye, Naijing and Liu, Jibin and Gao, Fei},
  title = {Colonic Submucosa Targeted Delivery of Probiotic and Rhein for Ulcerative Colitis Treatment},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {30},
  doi = {10.1002/advs.202409711}
}
Kostenlos starten →